CARM1 and ovarian carcinoma: This raises the possibility that diets or interventions that lowers lipid to increases saturated FAs may further improve the antitumor effects of SCD1 inhibition–based therapeutic approaches for several cancer types with frequent CARM1 overexpression and amplification including ovarian cancer (6–8).